Global Fortune 200 Pharmaceutical Company Selects Candelis ASTRATM Image Exchange Platform for Clinical Trials Image and Data Sharing The Customer A global, multi-billion dollar fortune 200 pharmaceutical company dedicates a large percentage of its investment dollars in R&D for the discovery and development of new medicines for patients, with product pipeline solutions for diseases including rheumatoid arthritis, hepatitis B, cancer, HIV/AIDS and diabetes. As an innovator in the pharmaceutical space, the company shares clinical trial information and data with patients, medical/research communities, the media, policy makers and the general public, consistent with the Principles for Responsible Clinical Trial Data Sharing (Principles) released by the U.S. and E

Join for free to read